EXOZYMES INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
EXOZYMES INC. (EXOZ) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 3.14 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-13
- EXOZYMES INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 2.65M shares, a 4.95% increase year-over-year.
- EXOZYMES INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 2.52M shares, a 158.22% increase year-over-year.
- EXOZYMES INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 977.47K shares.
- EXOZYMES INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 2.80M shares, a 111.89% increase from fiscal 2024.
- EXOZYMES INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 1.32M shares, a 39.34% increase from fiscal 2023.
- EXOZYMES INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 948.19K shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|
| 2026-06-30 | 3.14M shares 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | 2.65M shares 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | 2.80M shares 10-K · filed 2026-03-30 | |||
| 2025-09-30 | 2.78M shares 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | 2.07M shares 10-Q · filed 2026-08-13 | |||
| 2025-03-31 | 2.52M shares 10-Q · filed 2026-05-14 | |||
| 2024-12-31 | 1.32M shares 10-K · filed 2026-03-30 | |||
| 2024-09-30 | 1.12M shares 10-Q · filed 2025-11-13 | |||
| 2024-06-30 | 1.01M shares 10-Q · filed 2025-08-12 | |||
| 2024-03-31 | 977.47K shares 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | 948.19K shares 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |